1.Clinical observation of cutting fluctuations on central corneal thickness after laser subepithelial keratomileusis
Wei, CHENG ; Li-Jun, PU ; Ya-Fang, ZANG ; Ying-Ying, JIANG
International Eye Science 2017;17(9):1693-1696
AIM:To evaluate the percentage of cutting fluctuations of central corneal thickness (CCT) intraoperative used low concentration (0.02%) mitomycin C (MMC) after laser-assisted subepithelial keratomileusis (LASEK).METHODS:In this prospective study, low and medium myopia group(spherical equivalent≤6.0DS) has 138 patients (276 eyes).Low concentration MMC used topically in 69 patients(138 eyes)randomized after excimer laser ablation;the another traditional LASEK as control.High myopia group(6.0DS
2. Expression and role of CCAAT enhancer binding protein δ mRNA, microRNA ̄3553 and rno ̄Acad8_0002 of hepatocytes during the rat liver regeneration initiation
Ya-Fei LI ; Zi-Hui WANG ; Xia-Yan ZANG ; Wei JIN ; Cui-Fang CHANG ; Jian-Lin GUO ; Cun-Shuan XU ; Ya-Fei LI ; Zi-Hui WANG ; Xia-Yan ZANG ; Wei JIN ; Cui-Fang CHANG ; Jian-Lin GUO ; Cun-Shuan XU
Acta Anatomica Sinica 2021;52(6):917-920
Objective To explore the pathways and patterns which the CCAAT enhancer binding protein δ (CEBPδ) mRNA, miR-3553 and rno-Acad8_0002 regulate the hepatocytes in G
3. Expression and role of CCAAT enhancer binding protein a mRNA, microRNA-144-3p and three kinds of circular RNAs of hepatocytes during the rat liver regeneration initiation
Xia-Yan ZANG ; Zi-Hui WANG ; Ya-Fei LI ; Jian-Lin GUO ; Wei JIN ; Cun-Shuan XU ; Xia-Yan ZANG ; Zi-Hui WANG ; Ya-Fei LI ; Jian-Lin GUO ; Wei JIN ; Cun-Shuan XU ; Cui-Fang CHANG
Acta Anatomica Sinica 2021;52(6):901-908
Objective To explore the pathways and patterns which CCAAT enhancer binding proteina (CEBPα) mRNA, miR-144-3p, rno-LOC100365958_0001, rno-Usp3_0010 and rno-AC241873_0010 regulate the hepatocytes in G
4.Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Ming JIN ; Chang-Jiang XUE ; Yu WANG ; Fang DONG ; Yuan-Yuan PENG ; Ya-Dan ZHANG ; Bao-Xia ZANG ; Li TAN
Chinese journal of integrative medicine 2019;25(10):750-756
OBJECTIVE:
To investigate the attenuating effect of Hydroxysafflor yellow A (HSYA) on inflammatory injury in chronic obstructive pulmonary disease (COPD).
METHODS:
Rats were randomly assigned to 7 groups according to body weight including normal control group, HSYA blank group (76.8 mg/kg), COPD group, COPD+HSYA (30, 48, 76.8 mg/kg) groups and COPD+dexamethasone (2 mg/kg), 10 in each group. Passive cigarette smoke and intratracheal instillation of lipopolysaccharides were used to establish a COPD model in rats. Hematoxylin and eosin staining of lung tissue sections was used, real-time polymerase chain reaction (PCR) was used to assay mRNA levels of some cytokines in lung tissues, the cytokines in bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent assay (ELISA), Western blot analysis was used to determine phosphorylated p38 mitogen-activated protein kinase (MAPK) levels in lung tissues, and nuclear factor-κB (NF-κB) p65 protein levels in lung tissues were detected by immunohistochemistry.
RESULTS:
Lung alveolar septa destruction, alveolus fusion, inflammatory cell infiltration, and bronchiole exudation were observed. These pathological changes were alleviated in the COPD+HSYA group. The mRNA expression of inflammatory factors were significantly increased in lung tissues from COPD rats (all P<0.01) and were inhibited by HSYA. Levels of inflammatory cytokines in BALF of COPD rats were significantly increased (all P<0.01) which were inhibited by HSYA (all P<0.01, 48, 76.8 mg/kg). The levels of p38 MAPK phosphorylation and p65 in lung tissues of COPD rats were significantly increased (all P<0.01) and were suppressed by HSYA (all P<0.01, 48, 76.8 mg/kg).
CONCLUSIONS
HSYA could alleviate inflammatory cell infiltration and other pathological changes in the lungs of COPD rats. HSYA inhibited inflammatory cytokine expression, and increase phosphorylation of p38 MAPK and NF-κB p65 in the lungs of COPD rats. The protective mechanism of HSYA to inhibit COPD inflammation might be by attenuating NF-κB and p38MAPK signal transduction.